These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 26665508)

  • 21. The Dublin Consensus Statement 2011 on vital issues relating to the collection and provision of blood components and plasma-derived medicinal products.
    O'Mahony B; Turner A
    Vox Sang; 2012 Feb; 102(2):140-3. PubMed ID: 21806632
    [No Abstract]   [Full Text] [Related]  

  • 22. Plasma-collection plant has to overcome tainted-blood fallout in search for donors.
    OReilly M
    CMAJ; 1998 Feb; 158(3):380-1. PubMed ID: 9484267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemoglobin screening in prospective blood donors: comparison of different blood samples and different quantitative methods.
    Radtke H; Polat G; Kalus U; Salama A; Kiesewetter H
    Transfus Apher Sci; 2005 Aug; 33(1):31-5. PubMed ID: 15951241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003.
    Coste J; Reesink HW; Engelfriet CP; Laperche S; Brown S; Busch MP; Cuijpers HT; Elgin R; Ekermo B; Epstein JS; Flesland O; Heier HE; Henn G; Hernandez JM; Hewlett IK; Hyland C; Keller AJ; Krusius T; Levicnik-Stezina S; Levy G; Lin CK; Margaritis AR; Muylle L; Niederhauser C; Pastila S; Pillonel J; Pineau J; van der Poel CL; Politis C; Roth WK; Sauleda S; Seed CR; Sondag-Thull D; Stramer SL; Strong M; Vamvakas EC; Velati C; Vesga MA; Zanetti A
    Vox Sang; 2005 May; 88(4):289-303. PubMed ID: 15877653
    [No Abstract]   [Full Text] [Related]  

  • 25. American Red Cross to screen blood for Chagas' disease.
    McCarthy M
    Lancet; 2003 Dec; 362(9400):1988. PubMed ID: 14686364
    [No Abstract]   [Full Text] [Related]  

  • 26. At last--a national blood policy?
    Aledort LM
    Hosp Pract; 1979 Jul; 14(7):11, 15. PubMed ID: 478506
    [No Abstract]   [Full Text] [Related]  

  • 27. Canada's blood collection system should be reorganized, critics say.
    Senyk NA
    CMAJ; 1991 Feb; 144(3):274-5. PubMed ID: 1989699
    [No Abstract]   [Full Text] [Related]  

  • 28. Response rate of Malaysian blood donors with reactive screening test to transfusion medicine unit calls.
    Roshan TM; Rosline H; Ahmed SA; Rapiaah M; Khattak MN
    Southeast Asian J Trop Med Public Health; 2009 Nov; 40(6):1315-21. PubMed ID: 20578467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate-specific antigen assay using whole blood samples spotted on filter paper and its application to mass screening for prostate cancer.
    Nanri M; Nanri K; Fujiyama C; Tokuda Y; Nakamura K; Uozumi J
    Int J Urol; 2007 Jun; 14(6):505-9. PubMed ID: 17593094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Apropos of biological evaluation in blood donors. Results in 1031 blood donors].
    Selva J; Dorr R; Sievert J; Bloch M
    Rev Fr Transfus; 1970 Dec; 13(4):419-29. PubMed ID: 5511058
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmaceutical safety of red blood cells from whole blood donation in a military transfusion center.
    Putzker M; Bohnen H; Thöle A; Brandt D
    Clin Lab; 2002; 48(1-2):1-3. PubMed ID: 11833670
    [No Abstract]   [Full Text] [Related]  

  • 32. Medical devices alert. Subject: Transmission of blood-borne pathogens via spring-loaded lancet devices.
    Can J Med Technol; 1991; 53(1):51-2. PubMed ID: 10111697
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparison of homemade and imported HbsAg ELISA kits on screening blood samples].
    Liu FP; Liu JC; Wang DW
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):84-6. PubMed ID: 16816873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region.
    Pirard M; Iihoshi N; Boelaert M; Basanta P; López F; Van der Stuyft P
    Transfusion; 2005 Apr; 45(4):554-61. PubMed ID: 15819677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Status of NAT screening for HCV, HIV and HBV--experiences of the German Red Cross Blood Donation Services.
    Seifried E; Findhammer S; Roth WK
    Dev Biol (Basel); 2002; 108():23-7. PubMed ID: 12220139
    [No Abstract]   [Full Text] [Related]  

  • 36. [Alanine aminotransferase (ALAT, GPT): a reevaluation of exclusion limits for blood donors].
    Grunenberg R; Banik N; Krüger J
    Infusionsther Transfusionsmed; 1995 Jun; 22(3):145-51. PubMed ID: 7640509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Plasmodium vivax ELISA for the blood screen.
    Nam MH; Kim JS; Cho CH; Han ET; Lee WJ; Lee HK; An SS; Lim CS; Lee KN
    Trop Med Int Health; 2010 Dec; 15(12):1436-41. PubMed ID: 20955372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Donor exclusions, discarded blood and transfusion unsuited blood conserves of 2,13 million potential blood donors 1991 to 1994].
    Diekamp U; Wehrend W; Marklof E; Kamutzky K
    Beitr Infusionsther Transfusionsmed; 1996; 33():81-92. PubMed ID: 8974711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of rapid diagnostic tests for transfusion infectious screening in Africa: a literature review.
    Pruett CR; Vermeulen M; Zacharias P; Ingram C; Tayou Tagny C; Bloch EM
    Transfus Med Rev; 2015 Jan; 29(1):35-44. PubMed ID: 25447555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microarray blood testing: Pros & cons.
    Petrik J
    Biologicals; 2010 Jan; 38(1):2-8. PubMed ID: 20079661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.